Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Palisade Bio Plans 1-For-15 Reverse Split Of Its Common Stock

Author: Benzinga Newsdesk | April 03, 2024 05:31pm

Beginning on Monday, April 8, 2024, the Company's Common Stock will continue to trade on The Nasdaq Capital Market on a split adjusted basis under the trading symbol "PALI," but will trade under the following new CUSIP number starting April 8, 2024: 696389402. The reverse stock split is primarily intended to increase the Company's per share trading price and bring the Company into compliance with the Nasdaq's listing requirement regarding minimum share price.

Posted In: PALI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist